Related Experiment Video

Updated: May 10, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

[Natural evolution of excess body weight (overweight and obesity) in children]

T Durá Travé1, F Gallinas Victoriano,

  • 1Servicio de Pediatría, Complejo Hospitalario de Navarra, Servicio Navarro de Salud, Osasunbidea, Pamplona, España.

Anales De Pediatria (Barcelona, Spain : 2003)
|June 11, 2013
PubMed

Insights

Excess body weight in children begins early, with higher prevalence in males by age 14. This trend, linked to lifestyle, necessitates early intervention strategies.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Developmental Pediatrics

Context:

  • Childhood obesity is a growing global concern.
  • Understanding the onset and progression of excess body weight is crucial for effective public health strategies.

Purpose:

  • To analyze the chronological development of overweight and obesity in children.
  • To inform public awareness and intervention across family, school, and health sectors.

Summary:

  • A study tracked 604 children from birth to 14 years, measuring weight, height, and BMI.
  • Excess body weight was identified by age 4 and increased progressively, with higher prevalence in males (29%) versus females (12.8%) by age 14.
  • Body Mass Index (BMI) Z-scores indicated overweight or obesity starting at age 4 for those with excess weight at 14.

Impact:

  • Findings suggest excess body weight originates in early childhood, influenced by family dietary habits.
  • Interventions should target early life stages and address lifestyle factors during school years and adolescence.
Abstract

Keywords:
AdolescentesAdolescentsBody Mass IndexChildrenIndice de masa corporalNiñosObesidadObesityOverweightPrevalencePrevalenciaSobrepeso

More Related Videos

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil06:48

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Published on: July 29, 2020

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography13:09

Segmentation and Measurement of Fat Volumes in Murine Obesity Models Using X-ray Computed Tomography

Published on: April 4, 2012

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Hypodermis01:02

Hypodermis

The hypodermis (the subcutaneous layer or superficial fascia) is present directly below the dermis. It connects the skin to the underlying fascia (fibrous tissue) of the bones and muscles. It is not strictly a part of the skin, although the border between the hypodermis and dermis can be difficult to distinguish. The hypodermis consists of well-vascularized, loose, areolar connective tissue and adipose tissue, which functions as a mode of fat storage and provides insulation and cushioning for...